Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2023-02-28 2023-02-28
Drug Identification Number 00717002 00717002
Brand name VIADERM KC CRM VIADERM KC CRM
Common or Proper name VIADERM KC VIADERM KC
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients NYSTATIN GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE NYSTATIN GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE
Strength(s) 100000UNIT 0.25MG 2.5MG 1MG 100000UNIT 0.25MG 2.5MG 1MG
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL TOPICAL TOPICAL
Packaging size 30 30
ATC code D07CB D07CB
ATC description CORTICOSTEROIDS, COMB WITH ANTIBIOTICS CORTICOSTEROIDS, COMB WITH ANTIBIOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-11 2023-01-11
Estimated end date 2023-02-24 2023-02-24
Actual end date 2023-02-14 2023-02-14
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments